NGLY1 deficiency – clinical features and therapeutic strategy
Suzuki T. Catabolism of N-glycoproteins in mammalian cells: molecular mechanisms and genetic disorders related to the processes. Mol…
Plant Genetics Businesses, Ripe for Innovation, Pick Their M&A Partners
As emerging advancements in plant genetics buck the agriculture industry’s reputation for being slow to modernize, the opportunity…
U.S. DNA Synthesis Market Size
U.S. DNA Synthesis Market Summary The U.S. DNA synthesis market size was estimated at USD 1.25 billion in…
Chinese scientists map genetic resistance to wheat “cancer”
Chinese scientists have unveiled the world’s first genetic map tracking wheat resistance to the devastating yellow rust disease,…
North America Autoimmune Disease Diagnostics Market Report
Dublin, July 29, 2025 (GLOBE NEWSWIRE) — The “North America Autoimmune Disease Diagnostics Market Size and Share Analysis…
Genetic Testing Services Market Trends Through 2033: Key
Genetic Testing Services Market The global genetic testing services market is witnessing an impressive transformation, fueled by the…
Weekly genetics review: Managing mature cow size – new genetic insights
MATURE cow weight is a consistent theme of discussion among seedstock and commercial beef producers. Several recent Beef…
Lessons learned from a muscle study in nail-patella syndrome | Orphanet Journal of Rare Diseases
Clinical findings The patient is the second child of healthy, non-consanguineous parents, who first presented at the age…
Genetic Analysis Launches Microbiome Test in the US in Collaboration with Pangea Laboratory
Norwegian diagnostics company Genetic Analysis, in partnership with US-based Pangea Laboratory, is set to launch the microbiome-based GA-map…
TF Binding Mapped via DynaTag in Single Cells, Low-Input Samples
Mapping transcription factor (TF) binding sites across the genome is key to understanding how cells control gene expression,…
CRAFTseq: A New Tool for Mapping Disease Variant Effects in CRISPR-Edited Cells
Understanding the genetic drivers of human disease remains a major challenge. Researchers routinely use CRISPR, a gene-editing tool,…
Universal cancer vaccine? mRNA technology is promising
An experimental mRNA vaccine that supercharges existing cancer treatments could be laying the groundwork for a “universal” cancer…